The Prognostic Value of D-Dimer in Patients with Acute Myocardial Infarction: A Retrospective Longitudinal Cohort Study in Taiwan

Overview

Journal Acta Cardiol Sin

Date 2024 May 23

PMID 38779159

Authors

Zong-Yu Yu

Po-Kai Chan

Tzu-Chiao Lin

Yuan Hung

Fang-Han Yu

Wei-Shiang Lin

Shu-Meng Cheng

Wen-Yu Lin

Affiliations

Soon will be listed here.

Abstract

Background: Serum D-dimer level has been associated with worsening outcomes in patients with acute myocardial infarction. This study aimed to explore the association between serum D-dimer level and clinical outcomes in Taiwanese patients with acute myocardial infarction.

Methods: We analyzed Tri-Service General Hospital-Coronary Heart Disease registry data related to patients with acute myocardial infarction who were admitted between January 2014 and December 2018. A total of 748 patients were enrolled and categorized into high (≥ 495 ng/ml) and low (< 495 ng/ml) D-dimer groups. The primary endpoint was in-hospital mortality, and secondary endpoints were post-discharge mortality and post-discharge major adverse cardiovascular events.

Results: Overall, 139 patients died, with 77 from cardiovascular causes and 62 from non-cardiovascular causes. In-hospital mortality was higher in the high D-dimer group than in the low D-dimer group. Among the patients alive at discharge, those with a high D-dimer level had higher cardiovascular mortality and future major adverse cardiovascular events than those with a low D-dimer level. Multivariate Cox regression analysis revealed that higher serum D-dimer levels were significantly associated with higher risks of in-hospital mortality [hazard ratio (HR) = 1.11; 95% confidence interval (CI), 1.06-1.16, p < 0.001], subsequent cardiovascular mortality after discharge (HR = 1.15; 95% CI, 1.08-1.22, p < 0.001), and major adverse cardiovascular events (HR = 1.10; 95% CI, 1.04-1.16, p < 0.001).

Conclusions: This is the first study in Taiwan to demonstrate that a higher baseline serum D-dimer level was independently associated with higher risks of in-hospital mortality, post-discharge mortality, and major adverse cardiovascular events in patients with acute myocardial infarction.

References

Wang K, Chu P, Lee C, Pai P, Lin P, Shyu K . Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. Acta Cardiol Sin. 2016; 32(1):1-22. PMC: 4804936. DOI: 10.6515/acs20151228a. View

Di Castelnuovo A, De Curtis A, Costanzo S, Persichillo M, Olivieri M, Zito F . Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study. Haematologica. 2013; 98(9):1476-80. PMC: 3762106. DOI: 10.3324/haematol.2012.083410. View

Lu P, Gong X, Liu Y, Tian F, Zhang W, Liu Y . Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction. Am J Cardiol. 2020; 140:13-19. DOI: 10.1016/j.amjcard.2020.10.050. View

OGara P, Ascheim D, Casey Jr D, Chung M, de Lemos J, Ettinger S . 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012; 127(4):e362-425. DOI: 10.1161/CIR.0b013e3182742cf6. View

Ruopp M, Perkins N, Whitcomb B, Schisterman E . Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J. 2008; 50(3):419-30. PMC: 2515362. DOI: 10.1002/bimj.200710415. View

Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D . Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018; 72(18):2231-2264. DOI: 10.1016/j.jacc.2018.08.1038. View

Huang D, Gao W, Wu R, Zhong X, Qian J, Ge J . D-dimer level predicts in-hospital adverse outcomes after primary PCI for ST-segment elevation myocardial infarction. Int J Cardiol. 2020; 305:1-4. DOI: 10.1016/j.ijcard.2020.02.010. View

Cheng C, Yu F, Ko P, Lin H, Lin W, Cheng S . Prognostic Analysis of Patients with Acute Myocardial Infarction Undergoing Implantation of Different Stents for the First Time. J Clin Med. 2021; 10(21). PMC: 8584812. DOI: 10.3390/jcm10215093. View

Zhang X, Wang S, Sun L, Fang S, Yu B . Prognostic value of D-dimer in acute myocardial infarction complicated by heart failure with preserved ejection fraction. ESC Heart Fail. 2020; 7(6):4118-4125. PMC: 7755008. DOI: 10.1002/ehf2.13027. View

10.

Simes J, Robledo K, White H, Espinoza D, Stewart R, Sullivan D . D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study. Circulation. 2018; 138(7):712-723. DOI: 10.1161/CIRCULATIONAHA.117.029901. View

11.

Biccire F, Farcomeni A, Gaudio C, Pignatelli P, Tanzilli G, Pastori D . D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: asystematic review and metanalysis. Thromb J. 2021; 19(1):102. PMC: 8684263. DOI: 10.1186/s12959-021-00354-y. View

12.

Chen R, Liu C, Zhou P, Tan Y, Sheng Z, Li J . Prognostic Value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort study. Thromb J. 2021; 19(1):30. PMC: 8106213. DOI: 10.1186/s12959-021-00281-y. View

13.

Fu Y, Sun H, Guo Z, Xu L, Yang X, Wang L . A risk score model to predict in-hospital mortality of patients with end-stage renal disease and acute myocardial infarction. Intern Emerg Med. 2020; 16(4):905-912. DOI: 10.1007/s11739-020-02529-3. View

14.

Farooq V, Serruys P, Bourantas C, Zhang Y, Muramatsu T, Feldman T . Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation. 2013; 128(2):141-51. DOI: 10.1161/CIRCULATIONAHA.113.001803. View

15.

Choi S, Jang W, Song Y, Lima J, Guallar E, Choe Y . D-Dimer Levels Predict Myocardial Injury in ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study. PLoS One. 2016; 11(8):e0160955. PMC: 4981325. DOI: 10.1371/journal.pone.0160955. View

16.

Okamoto H, Kume T, Nishi T, Koto S, Sasahira Y, Yamada R . Efficacy of Optical Coherence Tomography-Guided Primary Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome. Acta Cardiol Sin. 2023; 39(2):266-276. PMC: 9999186. DOI: 10.6515/ACS.202303_39(2).20220729A. View

17.

Alkhalfan F, Kerneis M, Nafee T, Yee M, Chi G, Plotnikov A . D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy). Am J Cardiol. 2018; 122(9):1459-1464. DOI: 10.1016/j.amjcard.2018.07.032. View

18.

Lin W, Hung Y, Lin G, Lin C, Liou J, Cheng C . Profiles of Hospitalized Patients with Angiographic Coronary Heart Disease in Taiwan during 2014-2016: Report of a Tertiary Hospital. Acta Cardiol Sin. 2021; 37(4):365-376. PMC: 8261704. DOI: 10.6515/ACS.202107_37(4).20210118F. View

19.

Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P . Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of.... J Am Soc Echocardiogr. 2005; 18(12):1440-63. DOI: 10.1016/j.echo.2005.10.005. View

20.

Bjori E, Johnsen H, Hansen J, Braekkan S . D-dimer at venous thrombosis diagnosis is associated with risk of recurrence. J Thromb Haemost. 2017; 15(5):917-924. DOI: 10.1111/jth.13648. View